Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;43(2):1447-1448.
doi: 10.1007/s10072-021-05753-7. Epub 2021 Nov 17.

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson's disease patient

Elena Contaldi  1   2 , Cristoforo Comi  3 , Roberto Cantello  4 , Luca Magistrelli  4   5
Affiliations

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson's disease patient

Elena Contaldi et al. Neurol Sci. 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Bloem BR, Trenkwalder C, Sanchez-Ferro A, et al. COVID-19 vaccination for persons with Parkinson’s disease: light at the end of the tunnel? J Parkinsons Dis. 2021;11:3–8. doi: 10.3233/JPD-212573. - DOI - PMC - PubMed
    1. Erro R, Buonomo AR, Barone P, Pellecchia MT. Severe dyskinesia after administration of SARS-CoV2 mRNA vaccine in Parkinson’s disease. Mov Disord. 2021 doi: 10.1002/mds.28772. - DOI - PMC - PubMed
    1. Bettini E, Locci M. SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond. Vaccines (Basel) 2021;9:147. doi: 10.3390/vaccines9020147. - DOI - PMC - PubMed
    1. Grammatopoulos TN, Jones SM, Ahmadi FA, et al. Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. Mol Neurodegener. 2007;2:1. doi: 10.1186/1750-1326-2-1. - DOI - PMC - PubMed
    1. Reardon KA, Mendelsohn FAO, Chai SY, Horne MK. The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson’s disease. Aust N Z J Med. 2000;30:48–53. doi: 10.1111/j.1445-5994.2000.tb01054.x. - DOI - PubMed

Substances